Edinburgh Research Explorer Mendelian Randomisation study of the influence of eGFR on coronary heart disease

, , , , , Impaired kidney function, as measured by reduced estimated glomerular filtration rate (eGFR), has been associated with increased risk of coronary heart disease (CHD) in observational studies, but it is unclear whether this association is causal or the result of confounding or reverse causation. In this study we applied Mendelian randomisation analysis using 17 genetic variants previously associated with eGFR to investigate the causal role of kidney function on CHD. We used 13,145 participants from the UCL-LSHTM-Edinburgh-Bristol (UCLEB) Consortium and 194,427 participants from the Coronary ARtery DIsease Genome-wide Replication and Meta-analysis plus Coronary Artery Disease (CARDIoGRAMplusC4D) consortium. We observed significant association of an unweighted gene score with CHD risk (odds ratio = 0.983 per additional eGFR-increasing allele, 95% CI = 0.970–0.996, p = 0.008). However, using weights calculated from UCLEB, the gene score was not associated with disease risk (p = 0.11). These conflicting results could be explained by a single SNP, rs653178, which was not associated with eGFR in the UCLEB sample, but has known pleiotropic effects that

[1]  M. Woodward,et al.  Subclinical atherosclerosis measures for cardiovascular prediction in CKD. , 2015, Journal of the American Society of Nephrology : JASN.

[2]  S. Thompson,et al.  Instrumental Variable Analysis with a Nonlinear Exposure–Outcome Relationship , 2014, Epidemiology.

[3]  D. Lawlor,et al.  Testing for non-linear causal effects using a binary genotype in a Mendelian randomization study: application to alcohol and cardiovascular traits , 2014, International journal of epidemiology.

[4]  Z. Kutalik,et al.  Common variants in UMOD associate with urinary uromodulin levels: a meta-analysis. , 2014, Journal of the American Society of Nephrology : JASN.

[5]  C. Chute,et al.  The ATXN2-SH2B3 locus is associated with peripheral arterial disease: an electronic medical record-based genome-wide association study , 2014, Front. Genet..

[6]  Masood Ahmad,et al.  Coronary Artery Disease in Patients with Chronic Kidney Disease: A Clinical Update , 2013, Current cardiology reviews.

[7]  P. Visscher,et al.  Calculating statistical power in Mendelian randomization studies. , 2013, International journal of epidemiology.

[8]  A. Butterworth,et al.  Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data , 2013, Genetic epidemiology.

[9]  Tom R. Gaunt,et al.  Population Genomics of Cardiometabolic Traits: Design of the University College London-London School of Hygiene and Tropical Medicine-Edinburgh-Bristol (UCLEB) Consortium , 2013, PLoS ONE.

[10]  N. Sattar,et al.  Early-Life Overweight Trajectory and CKD in the 1946 British Birth Cohort Study , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  B. Pierce,et al.  Efficient Design for Mendelian Randomization Studies: Subsample and 2-Sample Instrumental Variable Estimators , 2013, American journal of epidemiology.

[12]  M. Fornage,et al.  Overlap between common genetic polymorphisms underpinning kidney traits and cardiovascular disease phenotypes: the CKDGen consortium. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  P. Whincup,et al.  Association between younger age when first overweight and increased risk for CKD. , 2013, Journal of the American Society of Nephrology : JASN.

[14]  J. Danesh,et al.  Large-scale association analysis identifies new risk loci for coronary artery disease , 2013 .

[15]  B. Astor,et al.  Combined association of albuminuria and cystatin C-based estimated GFR with mortality, coronary heart disease, and heart failure outcomes: the Atherosclerosis Risk in Communities (ARIC) Study. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  J. Gunawardana,et al.  Elevated circulating tissue factor procoagulant activity, factor VII, and plasminogen activator inhibitor‐1 in childhood obesity: evidence of a procoagulant state , 2012, British journal of haematology.

[17]  Christian Gieger,et al.  Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure , 2011, Nature Genetics.

[18]  Christian Gieger,et al.  Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk , 2011, Nature.

[19]  J. Wells,et al.  Socioeconomic Status and Reduced Kidney Function in the Whitehall II Study: Role of Obesity and Metabolic Syndrome , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  N. Mehta Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. , 2011, Circulation. Cardiovascular genetics.

[21]  M. Woodward,et al.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.

[22]  Uwe Völker,et al.  New loci associated with kidney function and chronic kidney disease , 2010, Nature Genetics.

[23]  P. Deloukas,et al.  Multiple common variants for celiac disease influencing immune gene expression , 2010, Nature Genetics.

[24]  P. O’Reilly,et al.  Genome-wide association study identifies eight loci associated with blood pressure , 2009, Nature Genetics.

[25]  D. de Zeeuw,et al.  Screening for albuminuria identifies individuals at increased renal risk. , 2009, Journal of the American Society of Nephrology : JASN.

[26]  J. Danesh,et al.  Renal Function and Risk of Coronary Heart Disease in General Populations: New Prospective Study and Systematic Review , 2007, PLoS medicine.

[27]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[28]  A. von Eckardstein,et al.  Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  Tom R. Gaunt,et al.  C-reactive protein and its role in metabolic syndrome: mendelian randomisation study , 2005, The Lancet.

[30]  C. Price,et al.  B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[31]  Robert M Califf,et al.  Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. , 2004, The New England journal of medicine.

[32]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[33]  Tim D. Spector,et al.  Obesity Is an Important Determinant of Baseline Serum C-Reactive Protein Concentration in Monozygotic Twins, Independent of Genetic Influences , 2004, Circulation.

[34]  B. Psaty,et al.  Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency , 2003, Circulation.